Pelayaran Nasional Ekalya Purnamasari Tbk. vs Merck Tbk. — how do they compare? Pelayaran Nasional Ekalya Purnamasari Tbk. trades at Rp1,005 (market cap 7.59T, 314.6K 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 20.9K 24h volume). The key difference: Pelayaran Nasional Ekalya Purnamasari Tbk. is far larger — about 4.5× Merck Tbk.'s market cap, and Pelayaran Nasional Ekalya Purnamasari Tbk. is more actively traded (314.6K versus 20.9K). Which is the better fit depends on your goals.
| ELPI | MERK | |
|---|---|---|
Market Cap | 7.59T | 1.7T |
Volume | 314.6K | 20.9K |
Lot | 3.15K | 209 |
Turnover | 310.29M | 80.13M |
Average Price | 986.31 | 3,833.92 |
Value | 310.29M | 80.13M |
Indicative Equilibrium Price | 990 | 3,850 |
Indicative Equilibrium Volume | 18.1K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Pelayaran Nasional Ekalya Purnamasari Tbk (the Entity) was established based on Notarial Deed No. 11 of Grace Margareth Goenawan, S.H., dated April 20, 1992 in Ambon. PT Pelayaran Nasional Ekalya Purnamasari is the parent Entity, whereas PT Kreasi Cipta Timur is the ultimate parent of the Entity. The Entity’s Ultimate Beneficiary Ownership (UBO) is Eka Taniputra.
Read more on ELPI →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →